NCT06354478View on ClinicalTrials.gov

IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

July 1, 2022

Conditions
Breast CancerPain, PostoperativePain, Acute
Interventions
DRUG

Dexmedetomidine Hydrochloride 0.5 MG/ML

Will be used either alone or in combination of gabapentin

DRUG

Gabapentin

Will be used either alone or in combination of Dexmedetomidine

Trial Locations (1)

Unknown

National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT06354478 - IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy | Biotech Hunter | Biotech Hunter